HY-W114781-10g
|
MedChemexpress LLC
|
4-Fluoro-N-methylbenzylamine [CAS 405-66-3]
|
|
|
|
HY-W114781-5g
|
MedChemexpress LLC
|
4-Fluoro-N-methylbenzylamine [CAS 405-66-3]
|
|
|
|
HY-W052234-1g
|
MedChemexpress LLC
|
4-Fluorophenoxyacetic acid [CAS 405-79-8]
|
|
|
|
HY-116022A-1g
|
MedChemexpress LLC
|
4-Nitrophenyl phosphate (disodium hexahydrate) [CAS 333338-18-4]
|
|
|
|
HY-W039519-1g
|
MedChemexpress LLC
|
7-Methoxycoumarin-3-carboxylic acid [CAS 20300-59-8]
|
|
Cancer-programmed cell death
|
|
HY-W039519-100mg
|
MedChemexpress LLC
|
7-Methoxycoumarin-3-carboxylic acid [CAS 20300-59-8]
|
|
Cancer-programmed cell death
|
|
HY-W039519-25mg
|
MedChemexpress LLC
|
7-Methoxycoumarin-3-carboxylic acid [CAS 20300-59-8]
|
|
Cancer-programmed cell death
|
|
HY-W039519-50mg
|
MedChemexpress LLC
|
7-Methoxycoumarin-3-carboxylic acid [CAS 20300-59-8]
|
|
Cancer-programmed cell death
|
|
HY-120833-1mg
|
MedChemexpress LLC
|
Ac-Ile-Glu-Thr-Asp-pNA [CAS 219138-21-3]
|
|
|
|
HY-120833-10mg
|
MedChemexpress LLC
|
Ac-Ile-Glu-Thr-Asp-pNA [CAS 219138-21-3]
|
|
|
|
HY-120833-25mg
|
MedChemexpress LLC
|
Ac-Ile-Glu-Thr-Asp-pNA [CAS 219138-21-3]
|
|
|
|
HY-120833-5mg
|
MedChemexpress LLC
|
Ac-Ile-Glu-Thr-Asp-pNA [CAS 219138-21-3]
|
|
|
|
HY-P81014-100uL
|
MedChemexpress LLC
|
Alexa Fluor� 405-conjugated AffiniPure Goat Anti-Mouse IgG H&L
|
|
|
|
HY-P81014-50uL
|
MedChemexpress LLC
|
Alexa Fluor� 405-conjugated AffiniPure Goat Anti-Mouse IgG H&L
|
|
|
|
HY-P81015-100uL
|
MedChemexpress LLC
|
Alexa Fluor� 405-conjugated AffiniPure Goat Anti-Rabbit IgG H&L
|
|
|
|
HY-P81015-50uL
|
MedChemexpress LLC
|
Alexa Fluor� 405-conjugated AffiniPure Goat Anti-Rabbit IgG H&L
|
|
|
|
HY-P70025-10ug
|
MedChemexpress LLC
|
Cystathionine gamma-lyase/CTH, Human
|
|
|
|
HY-P70025-50ug
|
MedChemexpress LLC
|
Cystathionine gamma-lyase/CTH, Human
|
|
|
|
HY-132850-10mg
|
MedChemexpress LLC
|
Dazcapistat [CAS 2221010-42-8]
|
|
COVID-19-immunoregulation
|
|
HY-132850-100mg
|
MedChemexpress LLC
|
Dazcapistat [CAS 2221010-42-8]
|
|
COVID-19-immunoregulation
|
|
HY-132850-25mg
|
MedChemexpress LLC
|
Dazcapistat [CAS 2221010-42-8]
|
|
COVID-19-immunoregulation
|
|
HY-132850-5mg
|
MedChemexpress LLC
|
Dazcapistat [CAS 2221010-42-8]
|
|
COVID-19-immunoregulation
|
|
HY-132850-50mg
|
MedChemexpress LLC
|
Dazcapistat [CAS 2221010-42-8]
|
|
COVID-19-immunoregulation
|
|
HY-132850-1mL
|
MedChemexpress LLC
|
Dazcapistat [CAS 2221010-42-8] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-153102-100mg
|
MedChemexpress LLC
|
G3-CNP [CAS 118291-90-0]
|
|
|
|